Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapy-related myelodysplasia and acute myeloid leukemia.

Seminars in oncology - 1 Dec 2013

Bhatia Smita

Abstract excerpt

Therapy-related leukemia (myelodysplasia and acute myeloid leukemia-t-MDS/AML) is a well-known complication of conventional chemoradiotherapy used to treat a variety of primary malignancies including Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL), sarcoma, and ovarian and testicular cancers. The median time to development of t-MDS/AML is 3-5 years, with the risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Chemoradiotherapy
Share to Hodgkin Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Non-Hodgkin

Share to Neoplasms, Second Primary

Share to Sarcoma

Share to Testicular Neoplasms

Share to Topoisomerase II Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 24331189
DOI: 10.1053/j.seminoncol.2013.09.013
PMCID: PMC3867743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapy-related myelodysplasia and acute myeloid leukemia.PMID 24331189Read ↗

Therapy-related myelodysplastic syndrome.Semantic proximity Read ↗

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.Semantic proximity Read ↗

Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.Semantic proximity Read ↗

Therapy-related myeloid leukemia.Semantic proximity Read ↗

Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASMSemantic proximity Read ↗

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic SyndromeSemantic proximity Read ↗

Genetics of therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Therapy-related myeloid neoplasms: when genetics and environment collide.Semantic proximity Read ↗

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesSemantic proximity Read ↗

Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.Semantic proximity Read ↗

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.